H2020Individual fellowship2019–2021

PoS · The price of success: what is the impact of improving patients’ survival on utilisation of care?

Horizon 2020 — Marie Skłodowska-Curie Actions

Duration
2019-09-01 → 2021-08-31
EU contribution
€219,312
Participants
1
Scheme
MSCA-IF-EF-ST

Lines connect the coordinator with its partners.

Results in brief

The price of success: what is the impact of improving patients’ survival on utilisation of care?

Health care expenditure absorbs a large share of public resources and is growing fast in many European countries. The drivers of this growth go beyond demographic factors and have not been properly investigated until recently due to the lack of good quality data following the population of health service users for a sufficient number of years. The Price of Success (PoS) research project aims to fill this gap in the knowledge by applying state-of-the-art econometric models to a very rich dataset on the population of Danish patients. The overarching hypothesis investigated by PoS is that a severe health shock, such as a stroke, AMI, hip fracture, is likely to leave a permanent mark on the ability of the individual to take care of herself and overcome the next episode, including completely unrelated episodes and small episodes of illness that were previously resolved without the need of a hospital visit. The remarkable success of new technologies and medical practices in extending the life expectancy of high-risk patients over the past decades might have increased the population of frequent users of the health system who were unlikely to survive a health shock in the past. The main objective of the project was to investigate the impact of such a “survival effect” on the rapid growth of the demand of health care services. The main objective was articulated in three research questions: R1: What is the impact of improving patient survival on subsequent costs of care? R2: Is the impact of the survival effect different according to patient’s characteristics? R3: To what extent can primary care reduce the use and costs of emergency secondary care?

Data: CORDIS, © European Union

Project objective

Unplanned emergency admissions absorb a large share of the resources allocated to the Health System and are growing at a fast rate in many European countries. The drivers of this growth go beyond demographic factors and have not been properly investigated until recently due to the lack of rich longitudinal datasets following a large population of patients for many years and a gap in the transfer of knowledge between Economics and Public Health disciplines. My ambition is to fill this gap in the knowledge by applying state-of-the-art econometric models to an exceptionally comprehensive and longitudinal dataset on the population of Danish patients, thus offering a unique opportunity to inform new policies on the appropriate tools to manage the growing demand for emergency care and the financial sustainability of the Health System, and policies aiming at reducing hospital readmissions. Access to new data, knowledge and training at the Danish Centre for Health Economics in SDU will allow me to greatly advance and expand my stream of research and will have a remarkable impact on my career development. The proposed research will address the following questions:1. What is the long-term impact of improving patients' survival on subsequent use and costs of care?2. To what extent can primary care reduce the use of secondary care following “the survival effect”?3. To what extent can higher integration of care between acute and post-acute services reduce the use of secondary care following the survival effect?4. Is the impact of the survival effect different according to patient’s socioeconomic characteristics? I will identify the profile of patients who are more likely to use care after surviving an acute event, and those who are more likely to benefit from primary care and integration of care interventions.

Original text from CORDIS.

Participants

  • SYDDANSK UNIVERSITET · Odense MCoordinatorDenmark

Links

Data: CORDIS, © European Union